Fig. 4From: Prediction of survival after eribulin chemotherapy for breast cancer by absolute lymphocyte counts and progression typesForest plots. A univariate analysis that validated the effect of OS showed that high ORR, high-ALC, and “high-ALC and PPL” were factors for a good prognosis (p < 0.001, HR = 0.310, 95% CI: 0.170–0.568; p = 0.027, HR = 0.505, 95% CI: 0.275–0.926; p = 0.009, HR = 0.407, 95% CI: 0.208–0.795)Back to article page